SPARTAN Group

Spondyloarthritis Research and Treatment Network

  • Become a SPARTAN Member
  • Donate
  • Contact Us
  • Log In
  • Home
  • About Us
    • About Spondyloarthritis
    • About SPARTAN
    • Corporate Supporters
    • Leadership
    • Committees
    • Awards
    • SPARTAN Newsletter Archives
    • Bylaws
  • Membership
    • Become a SPARTAN Member
    • Member Directory
  • Annual Meeting
    • 2023 SPARTAN Annual Meeting
    • 2023 Spondyloarthritis Review Course
    • 2023 Call for Trainee Abstracts
  • Projects
    • SPARTAN Projects
    • CLASSIC Study
  • Grants
    • Early Career Investigator Award
      • Early Career Investigator Award Application
    • Mentored Fellowship Award
      • Mentored Fellowship Award Application Form
    • SPARTAN Overhead Policy
  • Education
    • SPARTAN GRAPPA ASAS Symposium
    • CAPES Education Series
    • GRAPPA SPARTAN Global Education Seminars
    • Case Library
    • Treatment Guidelines
  • Members
    • Password Reset
    • Log Out

2023 Call for Trainee Abstracts

The SPARTAN Annual Symposium organizing committee invites trainees to submit an abstract to the annual symposium.
The deadline for submission is February 28, 2023. All abstracts will be evaluated by members of the abstract selection committee. Scientifically sound abstracts with relevance to spondyloarthritis (basic, clinical or translational research) will be accepted for poster presentation. The highest ranked abstracts will be invited for oral presentations and receive a $1000 travel award for a future meeting.

Eligibility:
Trainees include students, residents, fellows and postdocs. Results should not already have been published in a peer-reviewed journal. Abstracts presented at other meetings within one year are eligible for submission. Abstracts submitted to the SPARTAN Annual meeting may also be submitted to the ACR Annual Scientific meeting.
Logistics:
We are planning to meet in Cleveland for our annual meeting again May 19-20. The highest ranked abstracts will be presented in the scientific session. The remainder will be poster presentations. We will support travel and hotel for all trainees and poster submitters and expect  attendance at all sessions of the 2023 SPARTAN Annual Meeting including the Spondyloarthritis Review Course on May 18.
Abstract Format:
The abstract limit is 2,750 characters, which excludes the title, names of authors or co-authors, affiliations, spacing and disclosures. A maximum of 3 figures or tables is allowed. Each table or graphic will decrease the character count by 250 characters from the total limit allowed. Additional instructions:
  • Titles: Titles should be brief, representing the nature of the research. Use mixed case (do not use all caps) and do not put a period at the end of the title.
    Example: This is a Properly Formatted Abstract Title
    Please refrain from using acronyms in your abstract title. Acronyms may remain in the body of the abstract and in the author list.
  • Authors: Please consult with your co-authors on how they would like their names to appear. There is no limit on the number of authors for each abstract. All authors must disclose any relevant financial relationship(s) at the time of abstract submission.
  • Content: Organize content as follows:
    • Background: Background or Statement of Purpose
    • Methods: Methods, materials and analytical procedure used
    • Results: Summary of the results in sufficient detail to support conclusion
    • Conclusion: Conclusions reached (do not state “results will be discussed”).
  • Use of Product Names: The generic name should be used in your abstract. The proprietary drug name may appear once in parentheses in the title only. However, if a drug has not received FDA approval, only the non-proprietary name may be used in the title and abstract content.
  • Abbreviations: Place abbreviations in parentheses after the first time the full word appears. Do not abbreviate compounds in the title of the abstract. Use numerals to indicate numbers, except when beginning sentences.
Any work with human or animal subjects reported in submitted abstracts must comply with the guiding principles for experimental procedures found in the Declaration of Helsinki of the World Medical Association.
 
  • Submitter/Author

  • Co-Author(s)

  • All authors must disclose any relevant financial relationship(s) at the time of abstract submission. Relevant financial relationships consist of any financial arrangement between an author or their first-degree relative and a commercial entity that would be directly affected by the work (including stock/stock options, research grants, employment (full or part-time), ownership or partnership, consulting fees or other payments, receipt of royalties, and speakers’ bureaus).
  • Abstract

  • Please Include:
    Background: Background or Statement of Purpose
    Methods: Methods, materials and analytical procedure used
    Results: Summary of the results in sufficient detail to support conclusion
    Conclusion: Conclusions reached (do not state “results will be discussed”).
  • Please attach any supporting documents here.
    Drop files here or
    Max. file size: 100 MB, Max. files: 8.
    • Have all co-authors approved the final abstract submission?

    About US

    About SPARTAN
    Leadership
    Committees
    ByLaws

    Keep in Touch with SPARTAN

    Receive the SPARTAN email newsletter, published quarterly.

    Browse newsletter archives.

    Twitter @spartan_updates
    SPARTAN on LinkedIn

    Contact Us

    SPARTAN Office
    PO Box 55491
    Portland, OR 97238

    Copyright © 2023 SPARTAN · Log in